<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02487186</url>
  </required_header>
  <id_info>
    <org_study_id>012/2009</org_study_id>
    <nct_id>NCT02487186</nct_id>
  </id_info>
  <brief_title>Locally Delivered Doxycycline Adjunct to Nonsurgical Periodontal Therapy.</brief_title>
  <official_title>Evaluation of PLGA Microspheres Loaded With Doxycycline Associated to Periodontal Debridement in the Treatment of Chronic Advanced Periodontitis.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Campinas, Brazil</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Campinas, Brazil</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this clinical study is to asses the effect of ultrasonic periodontal debridement
      associated to locally delivered doxycycline (20%) by PLGA microspheres on chronic generalized
      periodontitis treatment.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Thirty patients with chronic periodontitis and a minimum of seven pockets (&gt;5

      mm) in non-molars teeth that bled on probing will be selected. Patients will be randomly

      assigned to ultrasonic periodontal debridement followed by local application of doxycycline

      by PLGA microspheres (DB+DOX) and periodontal debridement followed by administration

      of void PLGA microspheres (DB). Plaque, bleeding on probe, clinical attachment level

      (CAL), and probing depth (PD) will be recorded at baseline, 3 and 6 months. Subgingival

      biofilm samples will be collected from initially moderate (5 to 6 mm) and deep (≥7 mm)

      pockets at baseline, 1, 3 and 6 months. Polimerase chain reaction (PCR) analysis will be

      used to detect the frequency of Porphyromonas gingivalis (Pg), Tannerella forsythia (Tf),

      Treponema denticola (Td), Aggregatibacter actinomycetemcomitans (Aa), and Prevotella

      intermedia (Pi).
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2010</start_date>
  <completion_date type="Actual">June 2015</completion_date>
  <primary_completion_date type="Actual">December 2014</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Probing depht (PD)</measure>
    <time_frame>6 months</time_frame>
    <description>Probing depth (PD) will be measured at six sites per tooth by a PCP-15 periodontal Probe (Hu-Friedy - Chicago, IL, USA); This measure will be performed with the use of a plastic stent, presenting edges for the positioning of the stent probe.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Clinical attachment level (CAL)</measure>
    <time_frame>6 months</time_frame>
    <description>Six sites per tooth, will be measured with a PCP-15 Periodontal Probe (Hu-Friedy - Chicago, IL, USA). This measure will be performed with the use of a plastic stent, presenting edges for the positioning of the stent probe.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Periodontal Disease</condition>
  <arm_group>
    <arm_group_label>Test group: DB+DOX</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Test group: DB (full mouth debridment) +DOX (doxicicline) - 45 minutes of full-mouth debridement + subgingival application of PLGA microspheres loading doxycycline 10%.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group: DB alone</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Control group: DB alone (Full-mouth debridment)
Intervention: 45 minutes of full-mouth debridement + subgingival application of void PLGA microspheres.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Doxicicline</intervention_name>
    <description>Association of doxycycline (DOX) encapsulated in PLGA microspheres to ultrasonic debridment for the treatment of patients with chronic generalized periodontitis.</description>
    <arm_group_label>Test group: DB+DOX</arm_group_label>
    <other_name>PLGA microspheres</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Full-mouth debridment</intervention_name>
    <description>The patients will be treated by a single-session of periodontal debridement
during 45 minutes, using an ultrasonic instrument (Cavitron, Dentsply, Rio de
Janeiro, Brazil), under irrigation with sterile saline solution 20. After the debridement, local administration of microspheres loading doxycycline (DOX) (test) or empty microspheres (control) was performed.</description>
    <arm_group_label>Test group: DB+DOX</arm_group_label>
    <arm_group_label>Control group: DB alone</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Chronic generalized periodontitis (AAP,1999);

          -  At least 7 sites with probing depths &gt;5mm, and 2 sites with probing depth &gt;7mm;

          -  At least 20 teeth present;

          -  Systemically healthy.

        Exclusion Criteria:

          -  Had received periodontal care 6 months prior to the study;

          -  Had taken medications known to interfere with periodontal health and healing 6 months
             prior to the study;

          -  Pregnants or lactants;

          -  Smokers;

          -  Sensitive to doxycycline.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>35 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Enilson A Sallum, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Campinas, Brazil</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Piracicaba Dental School, State University of Campinas</name>
      <address>
        <city>Piracicaba</city>
        <state>São Paulo</state>
        <zip>13414-903</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>June 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 26, 2015</study_first_submitted>
  <study_first_submitted_qc>June 27, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 1, 2015</study_first_posted>
  <last_update_submitted>March 30, 2016</last_update_submitted>
  <last_update_submitted_qc>March 30, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 31, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Campinas, Brazil</investigator_affiliation>
    <investigator_full_name>Enilson Antonio Sallum</investigator_full_name>
    <investigator_title>Professor, department of Periodontics, Piracicaba Dental School, State University of Campinas (UNICAMP), Piracicaba, São Paulo, Brazil</investigator_title>
  </responsible_party>
  <keyword>Chronic periodontitis</keyword>
  <keyword>Local doxycycline</keyword>
  <keyword>Ultrasonic debridement</keyword>
  <keyword>PLGA microspheres</keyword>
  <keyword>Microbiologic assessment</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Periodontitis</mesh_term>
    <mesh_term>Periodontal Diseases</mesh_term>
    <mesh_term>Gingival Diseases</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Doxycycline</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

